Hims & Hers Health has appointed Deb Autor as its first chief policy officer to lead public policy and government functions, ...

After a tumultuous year, a popular virtual care platform is trying its hand in a competitive blood testing market.

Hims & Hers Health, Inc. could see more upside in partnerships and international expansion. Click here to read an analysis of ...

Hims & Hers Health’s ($HIMS) shares continued to plunge on Thursday despite the consumer telehealth company launching a new ...

Global populations are aging, a reality that is leading to increased demand for healthcare services, chronic disease ...

Shares of Mangoceuticals surged 28% ‌to $2.25 in premarket trading. U.S. regulations allow compounding pharmacies to copy ...

Trump’s GLP-1 price deal slashes costs and expands selective Medicare coverage—threatening telehealth startups and sparking a ...

How Ozempic Is Changing Thanksgiving According to the independent research and polling source KFF, one in eight Americans reported taking a GLP-1 receptor agonist ...

The White House may have struck a deal with Eli Lilly and Novo Nordisk last week to lower the costs of their weight loss ...

This expansion into diagnostics and tailored care represents a logical strategic extension of the company's telehealth model. Yet, the market's focus remained fixed on the worrying traffic and ...

Companies don’t generally cut prices out of generosity.

Plus, genetically engineered babies, antidepressant misconceptions and the first new malaria drug in years, in this issue of ...